Moderna’s RSV Vaccine Gets FDA Nod for Younger Adults!

Exciting news for younger adults at risk from RSV! The Food and Drug Administration (FDA) has expanded approval of Moderna’s RSV vaccine to include individuals aged 18 to 59. This…